Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2021 | Story Ruan Bruwer | Photo Johan Roux
Ox Nche during his playing days for the Shimlas in 2015. He might make a return to the Springbok team after three years.

It will be a small reunion for a couple of ex-Shimlas when almost the full Springbok squad gathers at Shimla Park this week.

This will then be the third week of training, but for the first time with the majority of the 46 squad members, as most players have finished their provincial and club commitments. They are preparing in Bloemfontein for the upcoming test season, which includes a test series against the British and Irish Lions.

Ox Nche (Shimlas 2015 and 2016) and Coenie Oosthuizen (2008) are members of the squad from which a Springbok and a South African A team will be chosen.

Both have represented the Springboks before – Nche in a single test in 2018, and Oosthuizen in 30 tests between 2012 and 2017.

Apart from the two players, there are three former University of the Free State students in the coaching staff. Rugby World Cup winning coach, Rassie Erasmus, is now the director of rugby at the South African Rugby Union, while former Bok defence coach (in 2018 and 2019), Jacques Nienaber, was promoted to head coach last year. The Springboks have not played a test under him yet.

The two first worked together in the Shimlas U20 team, where Erasmus was the captain and Nienaber the physio. Erasmus wore the famous blue jersey between 1993 and 1995. Daan Human, a former Shimla (1999-2000) and Shimla assistant coach, was appointed as the scrum coach of the national team last year.

Nche, a double Varsity Cup winner with the Young Guns in 2014 and the Shimlas in 2015, is strongly in the race for a place in the Springbok team.

Deon Davids, assistant coach of the Boks, recently had high praise for Nche.
“It is well-known that Ox is a quality player. Ox has been a consistent performer. His presence in the camp is an asset,” Davids said.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept